he purpose of this report was to update the 2006 International League Against Epilepsy (ILAE) report and identify the level of evidence for long-term efficacy or effectiveness for antiepileptic drugs (AEDs) as initial monotherapy for patients with newly diagnosed or untreated epilepsy. All applicable articles from July 2005 until March 2012 were identified, evaluated, and combined with the previous ysis (Glauser et al., 2006) to provide a comprehensive update.
The prior ysis methodology was utilized with three modifications: (1) the detectable noninferiority boundary approach was dropped and both failed superiority studies and prespecified noninferiority studies were yzed using a noninferiority approach, (2) the definition of an adequate comparator was clarified and now includes an absolute minimum point estimate for efficacy/effectiveness, and (3) the relationship table between clinical trial ratings, level of evidence, and conclusions no longer includes a recommendation column to reinforce that this review of efficacy/evidence for specific seizure types does not imply treatment recommendations.
This evidence review contains one clarification: The commission has determined that class I superiority studies can be designed to detect up to a 20% absolute (rather than relative) difference in the point estimate of efficacy/effectiveness between study treatment and comparator using an intent-to-treat ysis. Since July, 2005, three class I randomized controlled trials (RCT) and 11 class III RCTs he been published. The combined ysis (1940-2012) now includes a total of 64 RCTs (7 with class I evidence, 2 with class II evidence) and 11 meta-yses.
New efficacy/effectiveness findings include the following: levetiracetam and zonisamide he level A evidence in s with partial onset seizures and both ethosuximide and valproic acid he level A evidence in children with childhood absence epilepsy.
There are no major changes in the level of evidence for any other subgroup. Levetiracetam and zonisamide join carbamazepine and phenytoin with level A efficacy/effectiveness evidence as initial monotherapy for s with partial onset seizures. Although ethosuximide and valproic acid now he level A efficacy/effectiveness evidence as initial monotherapy for children with absence seizures, there continues to be an alarming lack of well designed, properly conducted epilepsy RCTs for patients with generalized seizures/epilepsies and in children in general.
These findings reinforce the need for multicenter, multinational efforts to design, conduct, and yze future clinically relevant adequately designed RCTs. When selecting a patient's AED, all relevant variables and not just efficacy and effectiveness should be considered.
查看信源地址
上一页:一文掌握脑瘤用药宝典
下一页:一文掌握癫痫服用宝典
- 2022-04-212013年该协会抗癫痫联合会抗癫痫药使用指南
- 2022-04-11FDA批准Aptiom用于治疗患者癫痫发作
- FDA批准Aptiom用于治疗患者癫痫发作
- 每个女人都是江湖……
- 孕妇能吃木瓜吗?
- 【用药问答】癫痫发作和局限性发作的首选治疗是什么?
- 如何治疗滴虫性阴炎?
- 患炎症该怎么办这四件小事很重要,要付诸行动
- 月经期间预防什么,避免细菌感染
- 儿童白癜风的原因是什么 儿童白癜风怎么办?
- 第四届妇科热点新进展学术研讨会
- Neurology CP:1例巨细胞动脉炎
- 结核病的早期症状是什么?
- 母乳┃哺乳期母亲如何避免乳腺炎?
- 艾叶能治疗妇科疾病吗?
- Cell重磅:解决了近百年的问题!研究发现了闪过记忆的潜在机制
- 结核性淋巴炎吃什么好
- 常见妇科炎症的相关问答
- 贝安健康:常见的妇科炎症有哪些类型?
- 什么?人工精子都出来了。!无精子症也可以生孩子
- 如何诊断妇科炎症?做什么检查?
- 英国为英国脱欧提供紧急医疗服务
- 知识:静脉逆入输卵管超声造影
- 前庭腺囊肿
- 宫颈糜烂的原因是什么?
- 雷安平,白癜风医院:科学防护有利于白癜风治疗
- 福州一医院用嫩模照片宣传妇科被判赔偿3.2 万
- 甲硝唑 VS 替硝唑,只是一字之差吗?
- 癫痫怎么住院?带你了解三大诊断手段
- 治疗癫痫病更为好的方法有哪些
- 原发癫痫病能治疗者吗
- 阿尔茨海默病或是生物特有疾病,同神经元及神经环路活性异常相关
- 癫痫病的病征有什么-
- 轻微癫痫的病因主要有哪些
- 怎样治疗癫痫病最必需
- 放射治疗癫痫病小发作药物
- 癫痫病的常见病因有哪些
- 天气越来越的水 癫痫患者预防病情有妙招
- 治疗癫痫病不错的方法是什么
- 长期口服抗癫痫用药会变“傻”吗?
- 治癫痫病哪里好视觉效果好吗
- 必要怎么样控制癫痫病